Nexrutine Inhibits Survival and Induces G1 Cell Cycle Arrest, Which Is Associated with Apoptosis or Autophagy Depending on the Breast Cancer Cell Line

REFERENCES

• Liu , R H . 2004 . Potential synergy of phytochemicals in cancer prevention: Mechanism of action . J Nutr , 134 : 3479S – 3485S .
   PubMed Web of Science ®Google Scholar
• Muralimanoharan , S B , Kunnumakkara , A B , Shylesh , B , Kulkarni , K H Haiyan , X . 2009 . Butanol fraction containing berberine or related compounds from Nexrutine inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells . Prostate , 69 : 494 – 504 .
   PubMed Web of Science ®Google Scholar
• Kumar , A P , Bhaskaran , S , Ganapathy , M , Crosby , K Davis , M D . 2007 . Akt/cAMP-responsive element binding protein/cyclin D1 network: A novel target for prostate cancer inhibition in transgenic adenocarcinoma of mouse prostate model mediated by Nexrutene . a Phellodendron Amurense. Clinical Cancer Res , 13 : 2784 – 2794 .
   PubMed Web of Science ®Google Scholar
• Garcia , G E , Nicole , A , Bhaskaran , S , Gupta , S Gupta , A . 2006 . Akt- and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phellodendron amurense extract . Neoplasia , 8 : 523 – 533 .
   PubMed Web of Science ®Google Scholar
• Lanza-Jacoby , S , Dicker , A P , Miller , S , Rosato , F E Flynn , J T . 2004 . Cyclooxygenase (COX)-2-dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2/neu mice . Mol Cancer Ther , 3 : 417 – 424 .
   PubMed Web of Science ®Google Scholar
• Wang , C , Pattabiraman , N , Zhou , J N , Fu , M , Sakamaki , T Albanese , C . 2003 . Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation . Mol Cell Biol , 23 : 6159 – 6173 .
   PubMed Web of Science ®Google Scholar
• Vermeulin , K , Van Bockstaele , D R and Berneman , ZN. 2003 . The cell cycle: a review of regulation, deregulation and therapeutic regulation, deregulation, and therapeutic targets . Cell Prolif , 36 : 131 – 149 .
   PubMed Web of Science ®Google Scholar
• Lehrke , M and Lazar , MA. 2005 . The many faces of PPARγ . Cell , 123 : 993 – 999 .
   PubMed Web of Science ®Google Scholar
• Saez , E , Rosenfeld , J , Livolsi , A , Olson , P Lombardo , E . 2004 . PPAR gamma signaling exacerbates mammary gland tumor development . Genes Dev , 18 : 528 – 540 .
   PubMed Web of Science ®Google Scholar
• Herman-Antosiewicz , A , Johnson , D and Singh , S . 2006 . Sulforaphane causes autophagy to inhibit release of cytochrome c and apoptosis in human prostate cancer cells . Cancer Res , 66 : 5828 – 5835 .
   PubMed Web of Science ®Google Scholar
• Fan , S , Meng , Q , Saha , T , Sarkar , F H and Rosen , E M . 2009 . “ Low concentrations of diindolylmethane, a metabolite of indole-3-carbinol, protect against oxidative stress in a BRCA1-dependent manner ” . In Cancer Res Vol. 69 , 6083 – 6091 .
   Google Scholar
• Kuo , P-L , Hsu , Y-L and Cho , C-Y . 2006 . Plumbagin induces G2-M arrest and autophagy by inhibiting the Akt/mammalian target of rapamycin pathway in breast cancer cells . Mol Cancer Ther , 5 : 3209 – 3221 .
   PubMed Web of Science ®Google Scholar
• Opipari , A W , Tan , L , Boitano , A E , Sorenson , D R Aurora , A . 2004 . Resveratrol-induced autophagocytosis in ovarian cancer cells . Cancer Res , 64 : 696 – 703 .
   PubMed Web of Science ®Google Scholar
• Ellington , A A , Berhow , M and Singletary , K W . 2005 . Induction of macroautophagy in human colon cancer cells by soybean B-group triterpenoid saponins . Carcinogenesis , 26 : 159 – 167 .
   PubMed Web of Science ®Google Scholar
• Aoki , H , Takada , Y , Kondo , S , Sawaya , R Aggarwal , B B . 2007 . Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-related kinases signaling pathways . Mol Pharmacol , 72 : 29 – 39 .
   PubMed Web of Science ®Google Scholar
• Half , E , Tang , X M , Gwyn , K , Sahin , A Wathen , K . 2002 . Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ . Cancer Res , 62 : 1676 – 1681 .
   PubMed Web of Science ®Google Scholar
• Ristimaki , A , Sivula , A , Lundin , J , Salinen , T Haglund , C . 2002 . Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer . Cancer Res , 62 : 632 – 635 .
   PubMed Web of Science ®Google Scholar
• Mehrotra , S , Morimiya , A , Agarwal , B , Konger , R and Badve , S . 2006 . Microsomal prostaglandin E2 synthase in breast cancer: a potential target for therapy . J Pathol , 208 : 356 – 363 .
   PubMed Web of Science ®Google Scholar
• Mueller , E , Sarraf , P , Tontonez , P , Evans , R M Martin , K J . 1998 . Terminal differentiation of human breast cancer through PPARγ . Mol Cell , 1 : 465 – 470 .
   PubMed Web of Science ®Google Scholar
• Clay , C E , Namen , A M and Atsumi , G . 1999 . Influence of J series of prostaglandins on apoptosis and tumorigenesis of breast cancer cells . Carcinogenesis , 20 : 1905 – 1911 .
   PubMed Web of Science ®Google Scholar
• Suh , N , Wang , Y , Williams , C R , Risingsong , R Gilmer , T . 1999 . A new ligand for the peroxisome proliferators-activated receptor γ GW7845 inhibits rat mammary carcinogensis . Cancer Res , 59 : 5671 – 5673 .
   PubMed Web of Science ®Google Scholar
• Elstner , E , Muller, Koshizuka , K , Williamson , E A Park , D . 1998 . Ligands for peroxisome proliferators-activated receptor γ and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice . Proc Natl Acad Sci , 95 : 8806 – 8811 .
   PubMed Web of Science ®Google Scholar
• Jiang , W G , Douglas-Jones , A and Mansel , R E . 2003 . Expression of peroxisome proliferators-activated receptor γ and PPARγ coactivator, PGC-1 in human breast cancer correlates with clinical outcome . Int J Cancer , 106 : 752 – 757 .
   PubMed Web of Science ®Google Scholar
• Kulkarni , S , Patil , D B , Diaz , L K , Wiley , E L Morrow , M . 2008 . COX-2 and PPARγ gene expression are potential markers of recurrence risk in mammary duct carcinoma in-situ . BMC Cancer , 8 : 36 – 47 .
   PubMed Web of Science ®Google Scholar
• Lefebvre , A M , Chen , I and Desreumaux , P . 1998 . Activation of the peroxisome proliferators-activated receptor promotes development of colon tumors in C57/BL/6J-APC min/+ mice . Nat Med , 4 : 1053 – 1057 .
   PubMed Web of Science ®Google Scholar
• Castrillo , A , Mojena , M , Hortelano , S and Bosca , L . 2001 . Peroxisome proliferators-activated receptor-γ-independent inhibition of macrophage activation by the non-thiazolidinedione agonist L-796,449. Comparison with the effects of 15-deoxy-delta (12,14)-prostaglandin J2 . J Biol Chem , 276 : 34082 – 34088 .
   PubMed Web of Science ®Google Scholar
• Pignatelli , M , Cocca , C , Santos , A and Perez-Castillo , A . 2003 . Enhancement of BRCA1 gene expression by peroxisome proliferators-activated receptor-γ in the MCF-7 breast cancer cell line . Oncogene , 22 : 5446 – 5450 .
   PubMed Web of Science ®Google Scholar
• Seargent , J M , Yates , E A and Gill , J H . 2004 . GW9662, a potent antagonist of PPARγ, inhibits growth of breast tumor cells and promotes the anticancer effects of PPARγ agonist rosiglitazone, independently of PPAR activation . British J Pharmacol , 143 : 933 – 937 .
   PubMed Web of Science ®Google Scholar
• Abbas , T and Dutta , A . 2009 . p21 in cancer: Intricate networks and multiple activities . Nat Rev Cancer , 9 : 400 – 414 .
   PubMed Web of Science ®Google Scholar
• Baehrecke , E H . 2005 . Autophagy: dual roles in life and death? . Nat Rev Mol Cell , 6 : 505 – 510 .
   PubMed Web of Science ®Google Scholar
• Gozuacik , D and Kimchi , A . 2004 . Autophagy as a cell death and tumor suppressor mechanism . Oncogene , 23 : 2891 – 2896 .
   PubMed Web of Science ®Google Scholar